WELLS FARGO & COMPANY/MN - CYTOKINETICS INC ownership

CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 355 filers reported holding CYTOKINETICS INC in Q2 2024. The put-call ratio across all filers is 0.61 and the average weighting 0.5%.

Quarter-by-quarter ownership
WELLS FARGO & COMPANY/MN ownership history of CYTOKINETICS INC
ValueSharesWeighting
Q2 2024$2,931,582
+2.8%
54,108
+33.1%
0.00%0.0%
Q1 2024$2,850,966
-7.3%
40,664
+10.4%
0.00%0.0%
Q4 2023$3,075,287
+23.6%
36,834
-56.4%
0.00%0.0%
Q3 2023$2,487,304
-25.7%
84,430
-17.8%
0.00%0.0%
Q2 2023$3,348,895
+29.5%
102,664
+39.7%
0.00%0.0%
Q1 2023$2,585,454
+126.8%
73,471
+195.3%
0.00%
Q4 2022$1,139,956
-1.0%
24,879
+4.7%
0.00%
Q3 2022$1,152,000
+19.6%
23,762
-3.0%
0.00%
Q2 2022$963,000
-76.0%
24,497
-77.5%
0.00%
-100.0%
Q1 2022$4,006,000
-25.8%
108,821
-8.1%
0.00%0.0%
Q4 2021$5,396,000
+82.5%
118,376
+43.1%
0.00%0.0%
Q3 2021$2,956,000
+246.9%
82,733
+92.3%
0.00%
Q2 2021$852,000
-55.4%
43,034
-47.6%
0.00%
Q1 2021$1,909,000
-41.8%
82,058
-48.0%
0.00%
-100.0%
Q4 2020$3,281,000
+22.7%
157,902
+27.9%
0.00%0.0%
Q3 2020$2,673,000
-14.1%
123,460
-6.5%
0.00%0.0%
Q2 2020$3,113,000
+115.7%
132,084
+7.9%
0.00%
Q1 2020$1,443,000
+10.4%
122,431
-0.7%
0.00%
Q4 2019$1,307,000
+10.0%
123,264
+18.1%
0.00%
Q3 2019$1,188,000
+17.9%
104,385
+16.6%
0.00%
Q2 2019$1,008,000
+334.5%
89,557
+211.7%
0.00%
Q1 2019$232,000
+28.9%
28,728
+0.8%
0.00%
Q4 2018$180,000
-35.0%
28,505
+1.3%
0.00%
Q3 2018$277,000
+27.6%
28,134
+7.4%
0.00%
Q2 2018$217,000
-57.6%
26,203
-63.2%
0.00%
Q1 2018$512,000
-13.1%
71,156
-1.5%
0.00%
Q4 2017$589,000
-19.6%
72,247
+43.0%
0.00%
Q3 2017$733,000
+78.3%
50,523
+48.7%
0.00%
Q2 2017$411,000
-18.6%
33,968
-13.6%
0.00%
Q1 2017$505,000
+55.4%
39,308
+46.9%
0.00%
Q4 2016$325,000
+125.7%
26,766
+71.3%
0.00%
Q3 2016$144,000
+2.1%
15,627
+5.1%
0.00%
Q2 2016$141,000
-66.0%
14,867
-74.7%
0.00%
Q1 2016$415,000
-30.9%
58,850
+2.5%
0.00%
Q4 2015$601,000
+33.9%
57,424
-14.4%
0.00%
Q3 2015$449,000
+3.5%
67,074
+3.9%
0.00%
Q2 2015$434,000
-38.0%
64,577
-37.5%
0.00%
Q1 2015$700,000
+1272.5%
103,348
+1502.3%
0.00%
Q4 2014$51,000
+218.8%
6,450
+43.6%
0.00%
Q3 2014$16,000
-90.6%
4,492
-87.4%
0.00%
Q2 2014$170,000
-67.0%
35,602
-34.2%
0.00%
Q1 2014$515,000
+8483.3%
54,140
+5314.0%
0.00%
Q4 2013$6,000
-25.0%
1,0000.0%0.00%
Q3 2013$8,0001,0000.00%
Other shareholders
CYTOKINETICS INC shareholders Q2 2024
NameSharesValueWeighting ↓
BVF INC/IL 5,721,888$46,633,0005.62%
IRONWOOD INVESTMENT MANAGEMENT LLC 107,139$873,0000.62%
Virtus ETF Advisers LLC 42,645$348,0000.44%
SPHERA FUNDS MANAGEMENT LTD. 210,000$1,712,0000.20%
LANSDOWNE PARTNERS (UK) LLP 2,647,981$21,581,0000.20%
WASATCH ADVISORS LP 1,679,778$13,690,0000.18%
PINNACLE ASSOCIATES LTD 877,575$7,152,0000.14%
ESSEX INVESTMENT MANAGEMENT CO LLC 107,728$878,0000.12%
Tekla Capital Management LLC 350,300$2,855,0000.11%
Financial Gravity Companies, Inc. 9,302$86,0000.10%
View complete list of CYTOKINETICS INC shareholders